Table of Content

1 Streptococcus Pneumoniae Vaccine Market Overview
1.1 Product Overview and Scope of Streptococcus Pneumoniae Vaccine
1.2 Streptococcus Pneumoniae Vaccine Segment by Type
1.2.1 Global Streptococcus Pneumoniae Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 7 -Valent
1.2.3 10 -Valent
1.2.4 13 -Valent
1.2.5 15 -Valent
1.2.6 23 -Valent
1.2.7 Other
1.3 Streptococcus Pneumoniae Vaccine Segment by Application
1.3.1 Global Streptococcus Pneumoniae Vaccine Market Value by Application: (2024-2034)
1.3.2 Children under 2 Years of Age
1.3.3 Adults over 65 Years of Age
1.3.4 Addicted Smokers Between the Ages of 19 and 64
1.3.5 Other
1.4 Global Streptococcus Pneumoniae Vaccine Market Size Estimates and Forecasts
1.4.1 Global Streptococcus Pneumoniae Vaccine Revenue 2018-2034
1.4.2 Global Streptococcus Pneumoniae Vaccine Sales 2018-2034
1.4.3 Global Streptococcus Pneumoniae Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Streptococcus Pneumoniae Vaccine Market Competition by Manufacturers
2.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Streptococcus Pneumoniae Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Streptococcus Pneumoniae Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Streptococcus Pneumoniae Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Streptococcus Pneumoniae Vaccine, Product Type & Application
2.7 Streptococcus Pneumoniae Vaccine Market Competitive Situation and Trends
2.7.1 Streptococcus Pneumoniae Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Streptococcus Pneumoniae Vaccine Players Market Share by Revenue
2.7.3 Global Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Streptococcus Pneumoniae Vaccine Retrospective Market Scenario by Region
3.1 Global Streptococcus Pneumoniae Vaccine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Streptococcus Pneumoniae Vaccine Global Streptococcus Pneumoniae Vaccine Sales by Region: 2018-2034
3.2.1 Global Streptococcus Pneumoniae Vaccine Sales by Region: 2018-2024
3.2.2 Global Streptococcus Pneumoniae Vaccine Sales by Region: 2024-2034
3.3 Global Streptococcus Pneumoniae Vaccine Global Streptococcus Pneumoniae Vaccine Revenue by Region: 2018-2034
3.3.1 Global Streptococcus Pneumoniae Vaccine Revenue by Region: 2018-2024
3.3.2 Global Streptococcus Pneumoniae Vaccine Revenue by Region: 2024-2034
3.4 North America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.4.1 North America Streptococcus Pneumoniae Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Streptococcus Pneumoniae Vaccine Sales by Country (2018-2034)
3.4.3 North America Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.5.1 Europe Streptococcus Pneumoniae Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2034)
3.5.3 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Streptococcus Pneumoniae Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.7.1 Latin America Streptococcus Pneumoniae Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Streptococcus Pneumoniae Vaccine Sales by Type (2018-2034)
4.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Type (2018-2024)
4.1.2 Global Streptococcus Pneumoniae Vaccine Sales by Type (2024-2034)
4.1.3 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Streptococcus Pneumoniae Vaccine Revenue by Type (2018-2034)
4.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Type (2018-2024)
4.2.2 Global Streptococcus Pneumoniae Vaccine Revenue by Type (2024-2034)
4.2.3 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Streptococcus Pneumoniae Vaccine Sales by Application (2018-2034)
5.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Application (2018-2024)
5.1.2 Global Streptococcus Pneumoniae Vaccine Sales by Application (2024-2034)
5.1.3 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Streptococcus Pneumoniae Vaccine Revenue by Application (2018-2034)
5.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Application (2018-2024)
5.2.2 Global Streptococcus Pneumoniae Vaccine Revenue by Application (2024-2034)
5.2.3 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GSK Streptococcus Pneumoniae Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Streptococcus Pneumoniae Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Abera
6.6.1 Abera Corporation Information
6.6.2 Abera Description and Business Overview
6.6.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abera Streptococcus Pneumoniae Vaccine Product Portfolio
6.7.5 Abera Recent Developments/Updates
6.8 S K Chemicals
6.8.1 S K Chemicals Corporation Information
6.8.2 S K Chemicals Description and Business Overview
6.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolio
6.8.5 S K Chemicals Recent Developments/Updates
6.9 Beijing Minhai Biotechnology
6.9.1 Beijing Minhai Biotechnology Corporation Information
6.9.2 Beijing Minhai Biotechnology Description and Business Overview
6.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolio
6.9.5 Beijing Minhai Biotechnology Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Baxter Streptococcus Pneumoniae Vaccine Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Biken
6.11.1 Biken Corporation Information
6.11.2 Biken Streptococcus Pneumoniae Vaccine Description and Business Overview
6.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Biken Streptococcus Pneumoniae Vaccine Product Portfolio
6.11.5 Biken Recent Developments/Updates
6.12 Celgene Corporation
6.12.1 Celgene Corporation Corporation Information
6.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Description and Business Overview
6.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolio
6.12.5 Celgene Corporation Recent Developments/Updates
6.13 Panacea Biotec
6.13.1 Panacea Biotec Corporation Information
6.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Description and Business Overview
6.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolio
6.13.5 Panacea Biotec Recent Developments/Updates
6.14 Serum Institute of India
6.14.1 Serum Institute of India Corporation Information
6.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Description and Business Overview
6.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolio
6.14.5 Serum Institute of India Recent Developments/Updates
6.15 Genentech
6.15.1 Genentech Corporation Information
6.15.2 Genentech Streptococcus Pneumoniae Vaccine Description and Business Overview
6.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Genentech Streptococcus Pneumoniae Vaccine Product Portfolio
6.15.5 Genentech Recent Developments/Updates
6.16 Genocea Biosciences
6.16.1 Genocea Biosciences Corporation Information
6.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Description and Business Overview
6.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolio
6.16.5 Genocea Biosciences Recent Developments/Updates
6.17 ImmunoBiology
6.17.1 ImmunoBiology Corporation Information
6.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Description and Business Overview
6.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolio
6.17.5 ImmunoBiology Recent Developments/Updates
6.18 Lupin
6.18.1 Lupin Corporation Information
6.18.2 Lupin Streptococcus Pneumoniae Vaccine Description and Business Overview
6.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Lupin Streptococcus Pneumoniae Vaccine Product Portfolio
6.18.5 Lupin Recent Developments/Updates
6.19 Nuron Biotech
6.19.1 Nuron Biotech Corporation Information
6.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Description and Business Overview
6.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolio
6.19.5 Nuron Biotech Recent Developments/Updates
6.20 Biogen
6.20.1 Biogen Corporation Information
6.20.2 Biogen Streptococcus Pneumoniae Vaccine Description and Business Overview
6.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Biogen Streptococcus Pneumoniae Vaccine Product Portfolio
6.20.5 Biogen Recent Developments/Updates
6.21 Valneva Austria
6.21.1 Valneva Austria Corporation Information
6.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Description and Business Overview
6.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolio
6.21.5 Valneva Austria Recent Developments/Updates
6.22 Sinovac
6.22.1 Sinovac Corporation Information
6.22.2 Sinovac Streptococcus Pneumoniae Vaccine Description and Business Overview
6.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolio
6.22.5 Sinovac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Streptococcus Pneumoniae Vaccine Industry Chain Analysis
7.2 Streptococcus Pneumoniae Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Streptococcus Pneumoniae Vaccine Production Mode & Process
7.4 Streptococcus Pneumoniae Vaccine Sales and Marketing
7.4.1 Streptococcus Pneumoniae Vaccine Sales Channels
7.4.2 Streptococcus Pneumoniae Vaccine Distributors
7.5 Streptococcus Pneumoniae Vaccine Customers
8 Streptococcus Pneumoniae Vaccine Market Dynamics
8.1 Streptococcus Pneumoniae Vaccine Industry Trends
8.2 Streptococcus Pneumoniae Vaccine Market Drivers
8.3 Streptococcus Pneumoniae Vaccine Market Challenges
8.4 Streptococcus Pneumoniae Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Streptococcus Pneumoniae Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Streptococcus Pneumoniae Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Streptococcus Pneumoniae Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Streptococcus Pneumoniae Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Streptococcus Pneumoniae Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Streptococcus Pneumoniae Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Streptococcus Pneumoniae Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Streptococcus Pneumoniae Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Streptococcus Pneumoniae Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Streptococcus Pneumoniae Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Streptococcus Pneumoniae Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Streptococcus Pneumoniae Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Streptococcus Pneumoniae Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Streptococcus Pneumoniae Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Streptococcus Pneumoniae Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Streptococcus Pneumoniae Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Streptococcus Pneumoniae Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Streptococcus Pneumoniae Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Streptococcus Pneumoniae Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Streptococcus Pneumoniae Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Streptococcus Pneumoniae Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Streptococcus Pneumoniae Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Streptococcus Pneumoniae Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Streptococcus Pneumoniae Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sanofi Streptococcus Pneumoniae Vaccine Product
Table 79. Sanofi Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GSK Streptococcus Pneumoniae Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Merck Streptococcus Pneumoniae Vaccine Product
Table 89. Merck Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Eli Lilly Streptococcus Pneumoniae Vaccine Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. AstraZeneca Streptococcus Pneumoniae Vaccine Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Abera Corporation Information
Table 101. Abera Description and Business Overview
Table 102. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Abera Streptococcus Pneumoniae Vaccine Product
Table 104. Abera Recent Developments/Updates
Table 105. S K Chemicals Corporation Information
Table 106. S K Chemicals Description and Business Overview
Table 107. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. S K Chemicals Streptococcus Pneumoniae Vaccine Product
Table 109. S K Chemicals Recent Developments/Updates
Table 110. Beijing Minhai Biotechnology Corporation Information
Table 111. Beijing Minhai Biotechnology Description and Business Overview
Table 112. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product
Table 114. Beijing Minhai Biotechnology Recent Developments/Updates
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Business Overview
Table 117. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Baxter Streptococcus Pneumoniae Vaccine Product
Table 119. Baxter Recent Developments/Updates
Table 120. Biken Corporation Information
Table 121. Biken Description and Business Overview
Table 122. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Biken Streptococcus Pneumoniae Vaccine Product
Table 124. Biken Recent Developments/Updates
Table 125. Celgene Corporation Corporation Information
Table 126. Celgene Corporation Description and Business Overview
Table 127. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Celgene Corporation Streptococcus Pneumoniae Vaccine Product
Table 129. Celgene Corporation Recent Developments/Updates
Table 130. Panacea Biotec Corporation Information
Table 131. Panacea Biotec Description and Business Overview
Table 132. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Panacea Biotec Streptococcus Pneumoniae Vaccine Product
Table 134. Panacea Biotec Recent Developments/Updates
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Business Overview
Table 137. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Serum Institute of India Streptococcus Pneumoniae Vaccine Product
Table 139. Serum Institute of India Recent Developments/Updates
Table 140. Genentech Corporation Information
Table 141. Genentech Description and Business Overview
Table 142. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Genentech Streptococcus Pneumoniae Vaccine Product
Table 144. Genentech Recent Developments/Updates
Table 145. Genocea Biosciences Corporation Information
Table 146. Genocea Biosciences Description and Business Overview
Table 147. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product
Table 149. Genocea Biosciences Recent Developments/Updates
Table 150. ImmunoBiology Corporation Information
Table 151. ImmunoBiology Description and Business Overview
Table 152. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. ImmunoBiology Streptococcus Pneumoniae Vaccine Product
Table 154. ImmunoBiology Recent Developments/Updates
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Business Overview
Table 157. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Lupin Streptococcus Pneumoniae Vaccine Product
Table 159. Lupin Recent Developments/Updates
Table 160. Nuron Biotech Corporation Information
Table 161. Nuron Biotech Description and Business Overview
Table 162. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Nuron Biotech Streptococcus Pneumoniae Vaccine Product
Table 164. Nuron Biotech Recent Developments/Updates
Table 165. Biogen Corporation Information
Table 166. Biogen Description and Business Overview
Table 167. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Biogen Streptococcus Pneumoniae Vaccine Product
Table 169. Biogen Recent Developments/Updates
Table 170. Valneva Austria Corporation Information
Table 171. Valneva Austria Description and Business Overview
Table 172. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Valneva Austria Streptococcus Pneumoniae Vaccine Product
Table 174. Valneva Austria Recent Developments/Updates
Table 175. Sinovac Corporation Information
Table 176. Sinovac Description and Business Overview
Table 177. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Sinovac Streptococcus Pneumoniae Vaccine Product
Table 179. Sinovac Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Streptococcus Pneumoniae Vaccine Distributors List
Table 183. Streptococcus Pneumoniae Vaccine Customers List
Table 184. Streptococcus Pneumoniae Vaccine Market Trends
Table 185. Streptococcus Pneumoniae Vaccine Market Drivers
Table 186. Streptococcus Pneumoniae Vaccine Market Challenges
Table 187. Streptococcus Pneumoniae Vaccine Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Streptococcus Pneumoniae Vaccine
Figure 2. Global Streptococcus Pneumoniae Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Streptococcus Pneumoniae Vaccine Market Share by Type in 2022 & 2034
Figure 4. 7 -Valent Product Picture
Figure 5. 10 -Valent Product Picture
Figure 6. 13 -Valent Product Picture
Figure 7. 15 -Valent Product Picture
Figure 8. 23 -Valent Product Picture
Figure 9. Other Product Picture
Figure 10. Global Streptococcus Pneumoniae Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Streptococcus Pneumoniae Vaccine Market Share by Application in 2022 & 2034
Figure 12. Children under 2 Years of Age
Figure 13. Adults over 65 Years of Age
Figure 14. Addicted Smokers Between the Ages of 19 and 64
Figure 15. Other
Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Streptococcus Pneumoniae Vaccine Market Size (2018-2034) & (US$ Million)
Figure 18. Global Streptococcus Pneumoniae Vaccine Sales (2018-2034) & (K Units)
Figure 19. Global Streptococcus Pneumoniae Vaccine Average Price (US$/Unit) & (2018-2034)
Figure 20. Streptococcus Pneumoniae Vaccine Report Years Considered
Figure 21. Streptococcus Pneumoniae Vaccine Sales Share by Manufacturers in 2022
Figure 22. Global Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Streptococcus Pneumoniae Vaccine Players: Market Share by Revenue in 2022
Figure 24. Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Streptococcus Pneumoniae Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 26. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2034)
Figure 27. North America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2034)
Figure 28. United States Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Canada Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2034)
Figure 31. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2034)
Figure 32. Germany Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. France Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. U.K. Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Italy Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Russia Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2018-2034)
Figure 38. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2018-2034)
Figure 39. China Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Japan Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. India Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Australia Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Taiwan Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Indonesia Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Thailand Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Malaysia Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Latin America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2034)
Figure 55. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. UAE Streptococcus Pneumoniae Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of Streptococcus Pneumoniae Vaccine by Type (2018-2034)
Figure 59. Global Revenue Market Share of Streptococcus Pneumoniae Vaccine by Type (2018-2034)
Figure 60. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Type (2018-2034)
Figure 61. Global Sales Market Share of Streptococcus Pneumoniae Vaccine by Application (2018-2034)
Figure 62. Global Revenue Market Share of Streptococcus Pneumoniae Vaccine by Application (2018-2034)
Figure 63. Global Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Application (2018-2034)
Figure 64. Streptococcus Pneumoniae Vaccine Value Chain
Figure 65. Streptococcus Pneumoniae Vaccine Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed